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Peripartum cardiomyopathy is definedas left ventricular
dilation and failure, first developing during the third
trimester of pregnancy or in the first 6 months postpar-
tum. In an effort to characterize this syndrome in a
middle class population, 14 consecutive patients with
peripartum cardiomyopathy underwent a detailed his-
tory and physical examination, right heart catheteriza-
tion, M-mode and two-dimensional echocardiography,
radionuclide ventriculography and right ventricular en-
domyocardial biopsy. These patients were then observed
with sequential noninvasive studies to determine prog-
nostic indicators.
Eight (57%) of these 14 patients were primiparous
and an equal number first presented with heart failure
concomitant with or immediately before the onset of
labor. When these women were compared with 55 pa-
tients with idopathic dilated cardiomyopathy, only mean
age at onset of symptoms (28.7 ± 5.7 versus 48.2 ±
13.6 years, p < 0.001) and symptom duration (4.1 ±
7.7 versus 19.0 ± 18.4 months, p < 0.001) differed
between the groups. There was no difference in ven-
Peripartum cardiomyopathy is defined as the onset of left
ventricular dilation and congestive heart failure detected
either during the third trimester of pregnancy or in the first
6 months postpartum (I). Although this syndrome is a rel-
atively rare cause of congestive heart failure, it has been
described more commonly in patients older than 30 years
of age, in multiparous or eclamptic patients and in twin
gestation (2). Several factors, including hypertension (3),
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tricular arrhythmia, left ventricular chamber size, ejec-
tion fraction or hemodynamics. Myocyte histologic find-
ings were similar; however, myocarditis was identified
in 29% of patients with peripartum cardiomyopathy and
in only 9% of those with idiopathic dilated cardio-
myopathy. In all patients with peripartum cardio-
myopathy and myocarditis, the myocardial biopsy was
performed within 1 week of onset of symptoms.
Seven (50%) of the patients with peripartum cardio-
myopathy had dramatic improvement within 6 weeks of
follow-up, and 6 (43%) died. Survivors had a higher
ejection fraction (22.8 ± 11.7 versus 10.6 ± 1.5%,
P < 0.05) and smaller left ventricular cavity size (5.8 ±
1.2 versus 6.9 ± 0.7 em, p < 0.05). Peripartum car-
diomyopathy in a middle class population is hemody-
namically indistinguishable from idiopathic dilated car-
diomyopathy but is characterized by a high incidence of
histologic myocarditis resulting in rapid, spontaneous
improvement of congestive heart failure or progressive
deterioration resulting in early death.
(J Am Coil Cardiol 1986;8:52-6)
nutritional or dietary discrepancies (4) and more recently,
myocarditis (5), have been implicated as possible causes of
peripartum cardiomyopathy.
Some reports (2,6) describe this syndrome in patients
from lower socioeconomic strata who may not have enjoyed
the benefit of high quality obstetric care. Peripartum car-
diomyopathy has not been systematically analyzed in women
receiving standard prenatal care nor have these patients been
evaluated with current invasive and noninvasive cardiac
techniques. The etiology of this form of dilated cardio-
myopathy remains controversial; namely, is peripartum car-
diomyopathy a specific disease of heart muscle or is the
presentation of congestive heart failure in the peripartal pe-
riod simply the initial presentation of latent idiopathic di-
lated cardiomyopathy? In an effort to clarify the precipi-
tating factors in a middle class population and further
characterize the features of this syndrome, we sequentially
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evaluated 14 patients with peripartum cardiomyopathy and
compared their clinical, hemodynamic, histologic and prog-
nostic characteristics with those of a nonselected group of
patients with idiopathic dilated cardiomyopathy.
ulation did so during the peripartal period and constitute the
study group.
Statistical analysis. This was performed using the chi-
square or the unpaired Student's t test. A probability value
of less than 0.05 was considered significant.
Table 1. Historic and Obstetric Characteristics
of 14 Patients With Peripartum Cardiomyopathy
Results
Clinical characteristics. Table 1 is a summary of the
cardiac history and obstetric characteristics of the 14 patients
with peripartum cardiomyopathy . Risk factors for the de-
velopment of coronary or myocardial disease, or both , were
unusual in this patient population and, by definition, no
patient had angiographic evidence of coronary artery dis-
ease . Only one individual was a cigarette smoker, two (14%)
were diabetic and none of these patients admitted to regular
alcohol use. Gestational hypertension was noted in four
(29%) of these women . A viral prodrome before the onset
of heart failure was noted in two patients (14%) .
Obstetric characteristics. These women had a broad
spectrum of obstetric presentations. Eight (57%) developed
heart failure concomitant with their first pregnancy and three
had one or more previous pregnancies without cardiac symp-
toms. Three of these women delivered their infant prema-
turely. Two patients developed heart failure in conjunction
with a twin gestation and six (43%) required cesarean section
for delivery of their infant. The initial presentation of cardiac
disease occurred before delivery in eight patients (57%) and
in the first week postpartum in three (Fig. 1). The high
incidence of prematurity and cesarean section in this patient
group may be a reflection of the development of heart failure
before delivery because each of these women became symp-
tomatic immediately before or concomitant with the onset
of labor. The remaining three patients first developed symp-
toms of heart failure between the second and eighth week
postpartum. None of these patients developed symptoms
Methods
Study patients. The patient population consisted of 14
consecutive women with peripartum cardiomyopathy re-
ferred to our center for diagnostic study . Peripartum car-
diomyopathy was defined as left ventricular dilation and
poor systolic function with normal wall thickness in the
presence of symptoms of congestive heart failure. The onset
had to commence during the third trimester of pregnancy
or within 6 months after parturition. These women all had
had high quality prenatal care and were without obvious
nutritional deficiencies. Patients with known cardiac disease
before pregnancy or evidence of valvular heart disease, peri-
cardial disease or preexistent hypertension were excluded .
Coronary angiography was performed in all patients over
30 years of age and in any patient with a suggestion of
ischemic heart disease by history , electrocardiographic
changes or coronary artery disease risk factors, that is, hy-
perlipidemia, family history of premature vascular disease,
history of cigarette smoking or diabetes mellitus. Subse-
quent angiographic documentation of coronary artery dis-
ease excluded patients from analysis.
The baseline evaluation performed on all patients in-
cluded a history and physical examination, right heart cath-
eterization with a flow-directed catheter and thermodilution
cardiac output recordings, right ventricular endomyocardial
biopsy using the Stanford technique (7), gated blood pool
scanning for the quantification of left and right ventricular
ejection fractions as well as segmental wall motion abnor-
malities and M-mode and two-dimensional echocardiog-
raphy. Gallium-67 imaging was attempted but breast uptake
in the postpartum women obscured visual interpretation of
myocardial uptake in both anterior and oblique views. Gated
blood pool scanning and echocardiography were repeated
every 3 months for the first year of follow-up. If active
myocarditi s was detected on initial biopsy, the biopsy was
repeated 6 weeks later. Patients were followed up closely
but no attempt was made to standardize medical therapy.
Baseline clinical , cardiac and obstetric variables were tab-
ulated and compared with defined risk factors for devel-
opment of peripartum cardiomyopathy as previously defined
by Demakis and Rahimtoola (2).
Control group. Baseline and follow-up characteristics
of the patients with peripartum cardiomyopathy were com-
pared with those of 55 consecutively evaluated patients with
idiopathic dilated cardiomyopathy. An age- and sex-matched
control group was not possible because the majority of young
women presenting with dilated cardiomyopathy in our pop-
Age (yr)
Cardiac risk factor (no.)
Cigarette smoking
Diabetes mellitus
Gestational hypertension
Ethanol use
Viral prodrome (no.)
Obstetric history (no.)
Primiparous
Multiparous
Premature infants
Twins
Cesarean section
*Mean ± SO.
28.7 ± 5.7*
1 (7%)
2 (14%)
4 (29%)
o
2 (14%)
8 (57%)
3 (21%)
3 (21%)
2 (14%)
6 (43%)
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Figure1. Distribution of time ofonset of symptoms in 14 patients
with peripartum cardiomyopathy. Pre = prepartum.
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than 30. Symptom duration was also significantly less in
the study group. Complex ventricular arrhythmia detected
by 24 hour ambulatory Holter monitoring was common in
both groups, occurring in 60% of the study group and 76%
of the patients with idiopathicdilated cardiomyopathy. Seg-
mental wall motion abnormalities were present on radio-
nuclide ventriculography in 8 (62%) of the patients with
peripartum cardiomyopathy and in 32 (64%) of the patients
with idiopathicdilated cardiomyopathy. Mean radionuclide
left ventricularejection fraction was similar in both groups.
Echocardiographic left ventricular enlargement was present
in both groups to an equal degree. The pulmonary artery
systolic pressure was similar in each group, as was the
pulmonary artery wedge pressure. A cardiac index of less
than 2.2 liters/min per m2 occurred with equal frequency in
each group (36% in both the study and comparison groups).
Findings on endomyocardial biopsy. Histologic ab-
normalities, including myocyte hypertrophy, nuclear hy-
perchromaticity and interstitial fibrosis, were qualitatively
Table 2. Clinical and Hemodynamic Comparison
Between Peripartum Cardiomyopathy and Idiopathic
Dilated Cardiomyopathy
after the eighth week postpartum. All delivered infants were
normal.
. Comparison with control cardiomyopathy group. In
an effort to ascertain whether peripartum cardiomyopathy
represents a unique form of heart disease or the initial pre-
sentation of latent idiopathic dilated cardiomyopathy, clin-
ical and hemodynamic comparisons were made between
these patients and 55 consecutive patients with idiopathic
dilated cardiomyopathy (Table 2). The group with peripar-
tumcardiomyopathy wasyounger;6 (43%)of the 14patients
were less than 30 years of age, whereas only 5 (9%) of the
55 patientswith idiopathicdilated cardiomyopathy were less
No. of patients
Age (yr)
Duration of symptoms (mo)
Complex ventricular
arrhythmia
Ejection fraction (%)
LVEDD (em)
Pressures (mm Hg)
PAsys
PAWmean
Cardiac index
(liters/min per rrr')
Peripartum
Cardiomyopathy
14
28.7 ± 5.7*
4.1 ± 7.7*
6 (60%)
18.1 ± 10.9
6.2 ± I.I
34.0 ± 13.6
17.8 ± 9.4
2.7 ± 1.0
Idiopathic Dilated
Cardiomyopathy
55
48.2 ± 13.6
19.0 ± 18.4
42 (76%)
18.8 ± 9.4
6.9 ± 1.0
42.0 ± 15.6
19.3 ± 9.3
2.2 ± 0.6
Figure 2. Endomyocardial biopsy with Iymphomononuclear in-
filtration (arrow) and myocyte necrosis indicative of myocarditis
inperipartum cardiomyopathy. (Hematoxylin-eosin stain, original
magnification x 200, reduced by 25%.)
,
*p < 0.001. LVEDD = left ventricular end-diastolic dimension; PAsys
= pulmonary artery systolic pressure; PAWmean = mean pulmonary artery
wedge pressure. Data expressed as mean ± SD.
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*p < 0.05. Data expressed as mean ± SD. Abbreviations as in
Table 2.
Table 3. Hemodynamic Comparison Between 8 Survivors and
6 Nonsurvivors of Peripartum Cardiomyopathy
similar in both groups. The incidence of active myocarditis,
defined as interstitial and perivascular lymphomononuclear
infiltration in the presence of myocyte necrosis with or with-
out fibrosis, was identified in four (29%) of the 14 patients
with peripartum cardiomyopathy (Fig. 2) and in only 5 (9%)
of the 55 patients with idiopathic dilated cardiomyopathy.
In each of the patients with peripartum cardiomyopathy and
myocarditis, the endomyocardial biopsy had been performed
within 1 week after the onset of symptoms, which repre-
sented a 67% incidence of myocarditis (four positive biop-
sies of six performed within 1 week of onset).
Treatment and follow-up. The study group was treated
with standard medical therapy for congestive heart failure,
restriction of activity and anticoagulant agents. Of the four
patients with biopsy-proven myocarditis, only one received
immunosuppressive therapy and she had a stable clinical
course without deterioration of clinical or hemodynamic
findings. The mean follow-up period was 12.1 ± 11.5
months for the patients with peripartum cardiomyopathy.
Six (43%) of the patients with peripartum cardiomyopathy
died during the follow-up period, whereas seven (50%) had
dramatic improvement with resolution of clinical symptoms,
discontinuation of cardiotonic medication, normalization of
the left ventricular end-diastolic dimension on echocardi-
ography and dramatic improvement of left ventricular ejec-
tion fraction (>20%); one patient remained clinically stable.
Of the four patients with active myocarditis on biopsy, two
died, one suddenly of a ventricular arrhythmia; the remain-
ing two survived, one in improved condition and one whose
condition stabilized.
Table 3 portrays the hemodynamic comparisons between
survivors and nonsurvivors. There was no significant dif-
ference in age between the two groups; however, ejection
fraction was substantially higher and left ventricular end-
diastolic dimension significantly smaller in the survivors.
Although there is a trend for more severe hemodynamic
abnormality in the nonsurvivors, this did not reach statistical
significance because of the small sample size.
No. of patients
Age (yr)
Ejection fraction (%)
LVEDD (em)
Pressures (mm Hg)
PA,y,
PAWmean
Cardiac index (liters/min per rrr')
Survivors
8
29.0 ± 5.9
22.8 ± 11.7*
5.8 ± 1.2*
32.3 ± 10.9
16.2 ± 8.7
3.0 ± 1.1
Nonsurvivors
6
28.3 ± 6.1
10.6 ± 1.5
6.9 ± 0.7
41.5 :!: 18.5
24.8 ± 7.9
2.2 :!: 0.6
Discussion
Clinical characteristics. This study describes the clin-
ical and hemodynamic presentation of 14 consecutively en-
countered women with peripartum cardiomyopathy. They
received compulsory prenatal care and had no obvious evi-
dence of dietary or nutritional deficiencies. Their obstetric
characteristics show some distinct differences from those
previously described in patients with peripartum cardio-
myopathy (2). Although a modest majority of these patients
were over 30 years of age at the time of presentation, the
incidence of delivery after age 30 is similar to that of our
contemporary obstetric population without peripartum car-
diomyopathy. Demakis and Rahimtoola (2) reported a higher
incidence in women after their third or subsequent preg-
nancy than after their first or second. This was not true in
our series; 57% of our patients were primiparous. In the
vast majority of women from the same metropolitan area
(Chicago) in the 1960s presenting with heart failure, the
failure developed 1 to 3 months after delivery (2), whereas
it occurred in fewer than 10% before delivery. This is an-
other distinct difference from our patients in that 8 (57%)
developed congestive heart failure before delivery. Fetal
outcome in our group of patients was excellent. Although
three infants were delivered prematurely, their growth and
development was normal. The 43% incidence of cesarean
section in our patient group reflects the current approach to
obstetric care in the patients with congestive heart failure.
Comparison with idiopathic dilated cardiomyopathy.
The critical question as to whether peripartum cardio-
myopathy represents a unique clinical entity or is merely
the first manifestation of latent heart disease that emerges
during the increased metabolic and hemodynamic demands
of pregnancy needs to be resolved. We attempted to identify
the unique aspects of this syndrome by comparing the study
patients with 55 patients with idiopathic dilated cardio-
myopathy. We realize that, ideally, age- and sex-matched
control subjects would be necessary to ascertain similarities
and differences; however, the development of a cardio-
myopathic state in young women other than during the peri-
partal period is unusual and makes strictly matched control
subjects impossible. Hemodynamic and clinical compari-
sons could not distinguish patients with peripartum cardio-
myopathy as a unique subgroup within the larger group of
patients with dilated cardiomyopathy.
Common clinical and hemodynamic characteristics were
not surprising, and we sought to further compare histologic
features. Myocyte hypertrophy, interstitial fibrosis and nu-
clear hyperchromaticity were common in both the compar-
ison and study groups. Deposition of proteinaceous mate-
rial, a unique finding previously reported by Sakakibara et
al. (8), was not found. The most intriguing difference, how-
ever, was noted in the incidence of myocarditis. Only 9%
of patients with idiopathic dilated cardiomyopathy had myo-
56 O'CONNELL ET AL.
PERIPARTUM CARDIOMYOPATHY
JACC Vol. 8, No. I
July 1986:52-6
carditis on biopsy. This rate is similar to our previously
reported incidence of myocarditis (9). The incidence of bi-
opsy-proven myocarditis in our patients with peripartum
cardiomyopathy was substantially higher (29%). Most in-
terestingly, myocarditis was identified only in individuals
who underwent biopsy within 1 week of the onset of symp-
toms. This suggests that myocarditis may play an important
role early in the development of peripartum cardiomyopathy
and may be missed if biopsy is performed later. A high
incidence of myocarditis was previously reported by Melvin
et al. (5). They identified myocarditis in three consecutive
patients presenting with peripartum cardiomyopathy. Their
patients were treated with immunosuppressive therapy and
showed significant improvement. Immunosuppressive ther-
apy was used in only one of our patients with myocarditis.
She had a stable clinical course after therapy. Two patients
died with active myocarditis; the other had dramatic im-
provement without immunosuppressive therapy.
Outcome of peripartum cardiomyopathy. The prog-
nosis of peripartum cardiomyopathy is distinctly different
from that of other forms of dilated cardiomyopathy. Of the
14 patients, 7 died during the follow-up period. All seven
patients whose condition improved had dramatic improve-
ment within 6 weeks of presentation. These results are sim-
ilar to those of Demakis and Rahimtoola (2). The small
number of patients precluded most statistical evaluations
between survivors and nonsurvivors except for ejection frac-
tion and left ventricular end-diastolic dimension; nonsur-
vivors had a lower mean ejection fraction and a higher mean
left ventricular end-diastolic dimension.
Etiologic factors: role of viral myocarditis. If peri-
partum cardiomyopathy represents a unique cardiomyop-
athy, etiologic factors that would characterize the unique
heart muscle abnormalities should be identifiable. Previ-
ously, dietary and nutritional factors were thought to con-
tribute to the development of congestive heart failure. This
seems less likely in a middle class urban population with
good prenatal care. We would propose a different etiologic
possibility in view of the documentation of a shift of onset
from 6 weeks postpartum to shortly before delivery and an
increased incidence of myocarditis. Pregnancy may predis-
pose women to a more severe form of viral myocarditis
when they are infected by a cardiotropic virus. Pregnant
mice have enhanced susceptibility to viral myocarditis when
they are infected with either Coxsackie or encephalomyo-
carditis viruses (10,11). Immunologic studies in women
have demonstrated enhanced suppressor cell activity during
pregnancy (12), which could augment susceptibility to viral
infections (13,14). Immunologic function begins to nor-
malize soon after delivery and this may enhance viral clear-
ance and account for the rapid lessening of symptoms and
hemodynamic abnormalities. The documented immunologic
abnormality of pregnancy serves as a basis for an attractive
hypothesis that peripartum cardiomyopathy is the result of
increased susceptibility of pregnant women to viral myo-
carditis.
Conclusion. Although this study has not defined peri-
partum cardiomyopathy as an entity distinct from idiopathic
dilated cardiomyopathy, the presence of congestive heart
failure during the peripartal period is associated with a high
incidence of myocarditis and a prognosis characterized by
either dramatic resolution of signs and symptoms over a
short period of time or continued deterioration resulting in
death. The previously described risk factors for the devel-
opment of this syndrome may no longer be valid. It is
therefore suggested that after early institution of medical
management, if further clinical deterioration is evident, early
cardiac transplantation in peripartum cardiomyopathy be
considered.
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